Cerezyme®
People with Gaucher disease type 1 may not have enough of an enzyme called acid beta-glucocerebrosidase (pronounced gloo-ko-ser-e-bro-sydaze) that breaks down a fatty substance called glucosylceramide (gloo-ko-sil-sara-mide), or GL-1. This may cause a build-up of GL-1 in key organs such as the spleen and liver, as well as in the bones, leading to the signs and symptoms of Gaucher disease type 1. Cerezyme® is a modified form of the enzyme glucocerebrosidase that reduces the build-up of GL-1 in the body.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Genzyme Corporation |
CLASS: Enzyme Replacement Therapy (ERT) |
PRESCRIBED BY: Various, including Gaucher Specialists |
HOW ADMINISTERED: IV Infusion |
FREQUENCY: Administered from three times a week to once every two weeks, based upon disease severity. |
Length of infusion: Generally one to two hours. In some cases, more than two hours. |
FOR MORE INFORMATION: |
